Mirtazapine
میرتازاپین
🧠 Nervous SystemAntidepressant
Market / country: 🇺🇸 USA
Remeron (US)
🧮 Dose calculator
Major depressive disorder · Regimen source: FDA Mirtazapine · 2.1
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ MAOI (incl. linezolid or IV methylene blue) or within 14 days. FDA Mirtazapine · 4
Formulations
- 15 mg tablet — tablet 🇺🇸 USA FDA Mirtazapine · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Mirtazapine · 8.1
“Risk Summary Prolonged experience with mirtazapine in pregnant women, based on published observational studies and postmarketing reports, has not reliably identified a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Mirtazapine · 8.2
“Risk Summary Data from published literature report the presence of mirtazapine in human milk at low levels with relative infant doses for mirtazapine ranging between 0.6 and 2.8% of the maternal weight-adjusted dose (see Data) .”
- 👶 ChildrenDangerous / avoid
Boxed warning in the label about children. FDA Mirtazapine · Boxed Warning
“Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Mirtazapine · 8.5
“Caution is indicated when administering mirtazapine to elderly patients [see Warnings and Precautions (5.12) , (5.15) and Clinical Pharmacology (12.3) ] .”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA076921
- DailyMed (FDA label)FDA Mirtazapine
- MedlinePlus (NIH)Mirtazapine
- WHO ATC/DDDN06AX11
- Darooyab (Iran)Mirtazapine
🇮🇷 Registered in Iran Darooyab · G-597/Mirtazapine
Dosage forms with Iranian generic codes, per Darooyab.
- 12197 · MIRTAZAPINE 15MG TAB · قرص میرتازاپین ۱۵ میلیگرم
- 08074 · MIRTAZAPINE 30MG TAB · قرص میرتازاپین ۳۰ میلیگرم
- 09475 · MIRTAZAPINE 45MG TAB · قرص میرتازاپین ۴۵ میلیگرم
- 52054 · MIRTAZAPINE 7.5MG TAB · قرص میرتازاپین ۷٫۵ میلیگرم
- 52053 · MIRTAZAPINE TABLET ORAL 45 mg · قرص میرتازاپین ۴۵ میلیگرم
- 52052 · MIRTAZAPINE TABLET ORAL 15 mg · قرص میرتازاپین ۱۵ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Mirtazapine · 3FDA Mirtazapine · 2.1FDA Mirtazapine · 4FDA Mirtazapine · 8.1FDA Mirtazapine · 8.2FDA Mirtazapine · Boxed WarningFDA Mirtazapine · 8.5FDA Mirtazapine · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-597/Mirtazapine
- Clinical review⚠ Unverified